Leading Neurology and Rare Disease Expert Dr. Nick France Joins FAST Board
FAST welcomes Dr. Nick France, a rare disease drug development leader from Alexion, AstraZeneca Rare Disease, to its Board of Directors, bringing two decades of biopharmaceutical and gene therapy expertise.